Fluoro-Metopon | Solubility of Things

Identification

Molecular formula

C₂₆H₂₈FN₃O

CAS number

255823-97-1

IUPAC name

1-[(4-fluorophenyl)methyl]-N-[1-[2-(4-methoxyphenyl)ethyl]-4-piperidyl]benzimidazol-2-amine

State

At room temperature, Fluoro-Metopon is in a solid state. It maintains its solid form under standard laboratory conditions, showing typical characteristics of organic compounds with a complex aromatic and heterocyclic system.

Melting point (Celsius)

209.00

Melting point (Kelvin)

482.15

Boiling point (Celsius)

465.00

Boiling point (Kelvin)

738.15

General information

Molecular weight

516.61g/mol

Molar mass

516.6090g/mol

Density

1.2430g/cm³

Appearence

Fluoro-Metopon typically appears as a crystalline solid. The crystal structure is usually well-defined, showcasing a clear to off-white color, depending on the specific synthesis and the purity of the compound.

Comment on solubility

Solubility of 1-[(4-fluorophenyl)methyl]-N-[1-[2-(4-methoxyphenyl)ethyl]-4-piperidyl]benzimidazol-2-amine

The solubility of 1-[(4-fluorophenyl)methyl]-N-[1-[2-(4-methoxyphenyl)ethyl]-4-piperidyl]benzimidazol-2-amine (C₂₆H₂₈FN₃O) can be a critical factor in its biological activity and application. Understanding its solubility characteristics provides insights into how it behaves in various environments.

Factors Affecting Solubility:

Molecular Structure: The presence of benzene rings and piperidine moieties can influence solubility, particularly in organic solvents.
Polarity: The presence of polar functional groups, such as the amine and methoxy groups, suggests the potential for higher solubility in polar solvents.
Temperature: Generally, solubility increases with temperature, which may assist in dissolving this complex organic molecule.
pH Levels: As a nitrogen-containing compound, its solubility may vary with changes in pH, depending on the ionization states of the amine groups.

General Observations:

In laboratory settings, this compound may display:

A relative insolubility in water, indicating hydrophobic characteristics due to its aromatic structure.
Improved solubility in organic solvents like ethanol or dimethyl sulfoxide (DMSO).
A propensity to form salts when reacted with acids, which can significantly enhance its aqueous solubility.

Overall, the solubility of this compound is a multifaceted topic that may require empirical study to fully elucidate its behavior in various solvents and conditions. As one researcher noted, "Understanding solubility is not just about how much will dissolve but also about the implications it holds for bioavailability and efficacy."

Interesting facts

Exploring 1-[(4-fluorophenyl)methyl]-N-[1-[2-(4-methoxyphenyl)ethyl]-4-piperidyl]benzimidazol-2-amine

This fascinating compound, often abbreviated in various ways, belongs to the group of benzimidazoles, which are notable for their diverse pharmacological profiles. As a scientist, understanding this compound unveils several interesting aspects:

Versatile Pharmacophore: The benzimidazole ring system is recognized for its **bioactive potential**. Compounds containing this structure often exhibit activities, including anti-inflammatory and anti-cancer properties.
Fluorine Impact: The inclusion of the fluorine atom in its structure can greatly enhance the compound's **lipophilicity** (fat affinity) and **metabolic stability**. This feature is a result of fluorine's unique ability to alter electronic properties.
Piperidine Linkage: The piperidine moiety contributes significantly to the compound’s **binding affinity** to various receptors, such as those in the central nervous system. This makes compounds like this appealing for potential therapeutic applications in treating psychiatric or neurological disorders.
Substituent Effects: The presence of methoxy groups and phenyl rings not only adds to the overall complexity of the molecule but may also impact its **interaction with biological targets**. These groups are known to participate in π-π stacking and hydrophobic interactions.

As with many complex organic compounds, the study of 1-[(4-fluorophenyl)methyl]-N-[1-[2-(4-methoxyphenyl)ethyl]-4-piperidyl]benzimidazol-2-amine offers an opportunity for discovery not just in terms of medicinal chemistry but also in **theoretical modeling** and **synthesis methods**. The exploration of such compounds contributes to the broader understanding of drug design and the ways in which molecular structure correlates with biological function.

"Chemistry is the essence of life itself." Understanding compounds like this one can lead to advancements in medicine and technology that improve our quality of life.

Synonyms

astemizole

68844-77-9

Hismanal

Histaminos

Paralergin

Laridal

Retolen

Astemisan

Astemison

Astemizol

Histamen

Kelp

Histazol

Wareezol

Novo-mastizol A

Astemizolum

Metodik

Waruzol

Astemizol [INN-Spanish]

Novo-nastizol a

1-[(4-Fluorophenyl)methyl]-N-[1-[2-(4-methoxyphenyl)ethyl]-4-piperidinyl]-1H-benzimidazol-2-amine

CCRIS 7595

GNF-PF-2461

HISMANAL (TN)

HSDB 6799

EINECS 272-441-9

1-(p-Fluorobenzyl)-2-((1-(p-methoxyphenethyl)-4-piperidyl)amino)benzimidazole

NSC-329963

NSC-759570

Alermizol

BRN 4830190

CHEBI:2896

1-[(4-fluorophenyl)methyl]-N-[1-[2-(4-methoxyphenyl)ethyl]piperidin-4-yl]benzimidazol-2-amine

R 42512

DTXSID9020110

ASTEMIZOLE [MI]

1-(p-Fluorobenzyl)-2-((1-(2-(p-methoxyphenyl)ethyl)piperid-4-yl)amino)benzimidazole

ASTEMIZOLE [INN]

ASTEMIZOLE [JAN]

ASTEMIZOLE [HSDB]

ASTEMIZOLE [USAN]

MFCD00153919

ASTEMIZOLE [VANDF]

NSC 329963

ASTEMIZOLE [MART.]

Astemizole [USAN:USP:INN:BAN:JAN]

ASTEMIZOLE [WHO-DD]

R 43,512

DTXCID30110

MLS000028667

CHEMBL296419

7HU6337315

Hestazol

Metodih

ASTEMIZOLE [USP IMPURITY]

NSC 759570

1-[(4-fluorophenyl)methyl]-N-{1-[2-(4-methoxyphenyl)ethyl]piperidin-4-yl}-1H-1,3-benzodiazol-2-amine

1H-Benzimidazol-2-amine, 1-((4-fluorophenyl)methyl)-N-(1-(2-(4-methoxyphenyl)ethyl)-4-piperidinyl)-

Astemizol [German]

NCGC00016913-08

SMR000058911

CAS-68844-77-9

Astemizol (INN-Spanish)

ASTEMIZOLE (MART.)

1-(4-fluorobenzyl)-N-{1-[2-(4-methoxyphenyl)ethyl]piperidin-4-yl}-1H-benzimidazol-2-amine

Benzimidazole, 1-(p-fluorobenzyl)-2-((1-(2-(p-methoxyphenyl)ethyl)piperid-4-yl)amino)-

Astemizolum [INN-Latin]

1H-Benzimidazol-2-amine, 1-[(4-fluorophenyl)methyl]-N-[1-[2-(4-methoxyphenyl)ethyl]-4-piperidinyl]-

ASTEMIZOLE (USP IMPURITY)

1-((4-Fluorophenyl)methyl)-N-(1-(2-(4-methoxyphenyl)ethyl)-4-piperidinyl)- 1H-benzimidazol-2-amine

Astemizole (USAN:USP:INN:BAN:JAN)

[3H]Astemizole

1-(4-fluorobenzyl)-2-(1-(4-methoxyphenethyl)piperidin-4-yl)aminobenzimidazole

1-(4-Fluorobenzyl)-2-(1-[4-methoxyphenethyl]piperidin-4-yl)aminobenzimidazole

1-(4-fluorobenzyl)-N-(1-(4-methoxyphenethyl)piperidin-4-yl)-1H-benzo[d]imidazol-2-amine

1-(p-Fluorobenzyl)-2-[[1-(p-methoxyphenethyl)-4-piperidyl]amino]benzimidazole

1-[(4-fluorophenyl)methyl]-N-(1-{2-[4-(methyloxy)phenyl]ethyl}piperidin-4-yl)-1H-benzimidazol-2-amine

1-[(4-Fluorophenyl)methyl]-N-{1-[2-(4-methoxyphenyl)ethyl]piperidin-4-yl}-1H-benzimidazol-2-amine

SR-01000003168

astemizolo

Lergibrumizol

Alerkin

Astemizole (JAN/USP/INN)

Hisamanal

Histalong

Acemiz

Stemiz

Astemizole?

MJD-30

Pollon-eze

1-(4-fluorobenzyl)-N-(1-(2-(4-methoxyphenyl)ethyl)piperidin-4-yl)-1H-benzimidazol-2-amine

Astemizole,(S)

Prestwick_35

UNII-7HU6337315

1-((4-fluorophenyl)methyl)-N-(1-(2-(4-methoxyphenyl)ethyl)piperidin-4-yl)-1H-1,3-benzodiazol-2-amine

1-((4-fluorophenyl)methyl)-N-(1-(2-(4-methoxyphenyl)ethyl)piperidin-4-yl)benzimidazol-2-amine

1-[(4-Fluorophenyl)methyl]-N-[1-[2-(4-methoxyphenyl)ethyl]-4-piperidinyl]-1H-benzimidazol-2-amine;Astemisan;Hismanal

XB7

Astemizole (Standard)

Opera_ID_62

Spectrum_000448

Prestwick0_000136

Prestwick1_000136

Prestwick2_000136

Prestwick3_000136

Spectrum2_001732

Spectrum3_001072

Spectrum4_001223

Spectrum5_001239

UPCMLD-DP024

cid_2247

SCHEMBL4385

REGID_for_CID_2247

BSPBio_000212

BSPBio_002684

KBioGR_001686

KBioSS_000928

1H-Benzimidazol-2-amine, 1-((4-fluorophenyl)methyl)-N-(1-(2-(4-methoxyphenyl)eth l)-4-piperidinyl)-

Astemizole, [O-Methyl-3H]

MLS001148073

DivK1c_000039

SPECTRUM2300094

SPBio_001804

SPBio_002151

Astemizole - Bio-X trade mark

BPBio1_000234

GTPL2603

Astemizole, >=98% (HPLC)

UPCMLD-DP024:001

BDBM24226

HMS500B21

KBio1_000039

KBio2_000928

KBio2_003496

KBio2_006064

KBio3_001904

R06AX11

NINDS_000039

HMS1568K14

HMS1922L12

HMS2090F14

HMS2093L18

HMS2095K14

HMS2234M17

HMS3373B08

HMS3413N12

HMS3677N12

HMS3712K14

HMS3751A17

Pharmakon1600-02300094

BCP16088

EX-A3350

Tox21_110680

Tox21_200095

CCG-39453

HY-12532R

NSC329963

NSC759570

STL301859

AKOS005064371

Tox21_110680_1

DB00637

FA18002

KS-5171

1-[(4-fluorophenyl)methyl]-N-[1-[2-(4-methoxyphenyl)ethyl]-4-piperidyl]benzimidazol-2-amine

IDI1_000039

QTL1_000010

NCGC00016913-01

NCGC00016913-02

NCGC00016913-03

NCGC00016913-04

NCGC00016913-05

NCGC00016913-06

NCGC00016913-07

NCGC00016913-09

NCGC00016913-10

NCGC00016913-11

NCGC00016913-12

NCGC00016913-14

NCGC00018288-01

NCGC00022520-03

NCGC00022520-04

NCGC00022520-05

NCGC00022520-06

NCGC00022520-07

NCGC00257649-01

AC-36371

BA300024

HY-12532

SBI-0051891.P002

AB00052413

CS-0011989

NS00008521

C06832

D00234

AB00052413-18

AB00052413_19

EN300-26506436

L001015

Q423437

R 45312

SR-01000003168-2

SR-01000003168-4

BRD-K37249724-001-05-9

BRD-K37249724-001-16-6

BRD-K37249724-001-24-0

BRD-K37249724-001-25-7

Astemizole, United States Pharmacopeia (USP) Reference Standard

1-(4-Fluorobenzyl)-N-(1-[2-(4-methoxyphenyl)ethyl]-4-piperidinyl)-1H-benzimidazol-2-amine #

1-(4-fluorophenylmethyl)-N-{1-[2-(4-methoxyphenyl)ethyl]-4-piperidinyl}-1H-benzimidazol-2-amine

272-441-9

Hismanal;1-[(4-Fluorophenyl)methyl]-N-[1-[2-(4-methoxyphenyl)ethyl]-4-piperidinyl]-1H-benzimidazol-2-amine